Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy is a research paper published in Molecular Therapy β Methods & Clinical Development (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: R01GM-119186
National Institutes of Health
Grant: R21 AR-081018
FWCI
4.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals